Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.53
+0.01 (0.13%)
Feb 4, 2026, 10:25 AM CST

SHE:002349 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
723.771,014921.76933.27651.59581.32
Trading Asset Securities
462.59105.16317.7124.95213.36114.74
Cash & Short-Term Investments
1,1861,1191,2391,058864.95696.06
Cash Growth
-11.41%-9.74%17.13%22.35%24.26%106.91%
Accounts Receivable
434.69414.58387.67339.16355.87367.25
Other Receivables
1.312.680.682.717.1922.56
Receivables
436417.26388.35341.86373.06389.81
Inventory
285.47270.35290.94307.65323.12307.78
Other Current Assets
46.7437.9567.0621.3133.9327
Total Current Assets
1,9551,8441,9861,7291,5951,421
Property, Plant & Equipment
581.96616.38663.36708.421,1691,211
Long-Term Investments
-356.9940.0246.9720.99100.77
Goodwill
167.94167.94167.94167.94167.94167.94
Other Intangible Assets
59.260.5262.5365.06123.24123.17
Long-Term Deferred Tax Assets
6.515.986.2212.5914.8817.46
Long-Term Deferred Charges
----37.9241.28
Other Long-Term Assets
717.66249.67259.13267.8925.0130.18
Total Assets
3,4883,3023,1853,0423,1983,156
Accounts Payable
150.18148.44141.94139.61213.06180.61
Accrued Expenses
48.78115.71123.65140.77107.6989.29
Short-Term Debt
-10.4320.9221.0368.7876.57
Current Portion of Long-Term Debt
----120.16-
Current Portion of Leases
0.190.751.180.681.77-
Current Income Taxes Payable
23.1911.1613.612.047.956.68
Current Unearned Revenue
13.8411.4413.645.130.4316.29
Other Current Liabilities
137.7527.6546.6235.4153.39159.05
Total Current Liabilities
373.93325.58361.51394.63603.24528.48
Long-Term Debt
-----120
Long-Term Leases
0.620.20.430.913.88-
Long-Term Unearned Revenue
11.1111.7310.8410.659.510.58
Long-Term Deferred Tax Liabilities
7.847.157.9612.0211.9310.23
Total Liabilities
393.5344.66380.75418.22628.54669.29
Common Stock
829.67814.18814.18814.18835.72835.72
Additional Paid-In Capital
818.5769769905.921,0171,017
Retained Earnings
1,106995.01860.5677.94514.59387.27
Treasury Stock
-56.71----132.2-132.2
Comprehensive Income & Other
8.445.30.912.891.140.13
Total Common Equity
2,7062,5832,4452,4012,2362,108
Minority Interest
388.19373.63359.67222.77333.72379.23
Shareholders' Equity
3,0942,9572,8042,6242,5702,487
Total Liabilities & Equity
3,4883,3023,1853,0423,1983,156
Total Debt
0.8111.3822.5422.62194.59196.57
Net Cash (Debt)
1,1861,1071,2171,036670.36499.49
Net Cash Growth
-10.39%-9.00%17.51%54.48%34.21%-
Net Cash Per Share
1.451.361.491.270.820.61
Filing Date Shares Outstanding
829.67814.18814.18814.18814.18814.18
Total Common Shares Outstanding
829.67814.18814.18814.18814.18814.18
Working Capital
1,5811,5191,6241,334991.83892.17
Book Value Per Share
3.263.173.002.952.752.59
Tangible Book Value
2,4792,3552,2142,1681,9451,816
Tangible Book Value Per Share
2.992.892.722.662.392.23
Buildings
-575570.97567.6949.94743.33
Machinery
-638.6618.06619.1695.42649.6
Construction In Progress
-53.5769.4261.5159.36273.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.